Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
N-Spine was a medical device company focused on developing innovative solutions for the treatment of lumbar spinal disorders. The company's primary product, the N-Flex DNA Stabilization System, was designed to provide dynamic stabilization to the spine as an alternative to rigid fusion. By allowing for controlled motion while maintaining stability, the technology aimed to treat degenerative conditions while potentially reducing the incidence of adjacent segment disease. N-Spine's approach utilized advanced materials to mimic the natural biomechanics of the human spine. The company was acquired by Synthes in 2007 to bolster its portfolio of non-fusion spinal implants and motion preservation technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on N Spine.